VOLUME 69 2008 NUMBER 5
Original Articles
693 Trauma and Posttraumatic Stress Disorder in the Elderly: Findings From a
German Community Study. [CME] Carsten
Spitzer, Sven Barnow, Henry Völzke, Ulrich John, Harald J. Freyberger, and Hans
Joergen Grabe
[Abstract]
[PDF]
701 A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine
in Outpatients With Bipolar Disorder and Alcohol Use Disorders. E. Sherwood
Brown, Monica Garza, and Thomas J. Carmody
[Abstract]
[PDF]
706 Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or
Obesity: A 16-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Grigori Joffe, Pirjo Takala, Evgueni Tchoukhine, Helinä Hakko, Mirjam Raidma,
Hanna Putkonen, Markku Eronen, and Pirkko Räsänen
[Abstract]
[PDF]
712 Long-Term Stability of Cognitive Impairment in Bipolar Disorder: A 2-Year
Follow-Up Study of Lithium-Treated Euthymic Bipolar Patients.
[CME] Maria Mur, Maria J. Portella, Anabel Martínez-Arán, Josep
Pifarré, and Eduard Vieta
[Abstract]
[PDF]
720 Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory
Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Jae Seung Chang, Yong Min Ahn, Hye Jean Park, Kyu Young Lee, Se Hyun Kim, Ung Gu
Kang, and Yong Sik Kim
[Abstract]
[PDF]
732 Family Treatment for Bipolar Disorder: Family Impairment by Treatment
Interactions. Ivan W. Miller, Gabor I. Keitner, Christine E. Ryan, Lisa A.
Uebelacker, Sheri L. Johnson, and David A. Solomon
[Abstract]
[PDF]
741 Predicted Risk of Diabetes and Coronary Heart Disease in Patients With
Schizophrenia: Aripiprazole Versus Standard of Care. Lawrence Blonde, Hong J.
Kan, Elane M. Gutterman, Gilbert J. L'Italien, Myoung S. Kim, Linda Hanssens,
and Robert D. McQuade
[Abstract]
[PDF]
749 Diagnosis of Unipolar Depression Following Initial Identification of
Bipolar Disorder: A Common and Costly Misdiagnosis. Michael D. Stensland,
Jennifer F. Schultz, and Jennifer R. Frytak
[Abstract]
[PDF]
759 Life-Threatening Clozapine-Induced Gastrointestinal Hypomotility: An
Analysis of 102 Cases. Susanna E. Palmer, Rachael M. McLean, Peter M. Ellis,
and Mira Harrison-Woolrych
[Abstract]
[PDF]
769 Efficacy of Quetiapine Monotherapy for the Treatment of Depressive
Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2
Double-Blind, Randomized, Placebo-Controlled Studies. Richard H. Weisler,
Joseph R. Calabrese, Michael E. Thase, Robert Arvekvist, Göran Stening, Björn
Paulsson, and Trisha Suppes
[Abstract]
[PDF]
783 A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist
Naltrexone in the Treatment of Pathological Gambling Urges. Jon E. Grant,
Suck Won Kim, and Boyd K. Hartman
[Abstract]
[PDF]
790 An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of
Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia.
John Lauriello, Tim Lambert, Scott Andersen, Daniel Lin, Cindy C. Taylor, and
David McDonnell
[Abstract]
[PDF]
800 Depression, Diabetes, and Glycemic Control in an American Indian
Community. Puneet K. C. Sahota, William C. Knowler, and Helen C. Looker
[Abstract]
[PDF]
810 Depression Comorbidity and Antidepressant Use in Veterans With Chronic
Hepatitis C: Results From a Retrospective Chart Review. Julie A. Nelligan,
Jennifer M. Loftis, Annette M. Matthews, Betsy L. Zucker, Alex M. Linke, and
Peter Hauser
[Abstract]
[PDF]
817 Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets
in the Treatment of Acute Schizophrenia: Pooled Data From Three 6-Week,
Placebo-Controlled Studies. Herbert Y. Meltzer, William V. Bobo, Isaac F.
Nuamah, Rosanne Lane, David Hough, Michelle Kramer, and Marielle Eerdekens
[Abstract]
[PDF]
Focus on Childhood and Adolescent Mental Health
830 Mood Disorders: Assessment, Risk Factors, and Outcome. Melissa P.
DelBello
[PDF]
831 Developing a 10-Item Mania Scale From the Parent General Behavior
Inventory for Children and Adolescents. Eric A. Youngstrom, Thomas W.
Frazier, Christine Demeter, Joseph R. Calabrese, and Robert L. Findling
[Abstract]
[PDF]
840 A Parent General Behavior Inventory Subscale to Measure Sleep Disturbance
in Pediatric Bipolar Disorder. Oren I. Meyers and Eric A. Youngstrom
[Abstract]
[PDF]
844 One-Year Course and Predictors of Outcome of Adolescent Depression: A
Case-Control Study in Finland. Linnea Karlsson, Olli Kiviruusu, Jouko
Miettunen, Hannele Heilä, Matti Holi, Titta Ruuttu, Virpi Tuisku, Mirjami
Pelkonen, and Mauri Marttunen
[Abstract]
[PDF]
854 Psychological Adjustment of Adolescents 18 Months After the Terrorist
Attack in Beslan, Russia: A Cross-Sectional Study. Ughetta Moscardino, Sara
Scrimin, Fabia Capello, Gianmarco Altoè, and Giovanna Axia
[Abstract]
[PDF]
ASCP Corner
860 Antipsychotic Polypharmacy, Part 2: Why Use 2 Antipsychotics When 1 Is
Not Good Enough? Christoph U. Correll
[PDF]
Letters To the Editor [PDF]
862 A Case of Sodium Oxybate Treatment of Tardive Dyskinesia and Bipolar
Disorder. Jon E. Berner
862 Aripiprazole Joins the Family of Second-Generation Mood Stabilizers.
Janusz K. Rybakowski
863 Intrinsic Activity of Aripiprazole Is Not 30% of Dopamine, But Only About
6% Under Ideal Antipsychotic Therapy. Takashi Hamamura, Masafumi Kodama, and
Toshiki Harada
- Reply by Sheldon H. Preskorn
865 Does Venlafaxine Maintenance Therapy Prevent Depression Recurrences or Drug
Discontinuation Reactions? Jon Jureidini and Barbara Mintzes
- Reply by Martin B. Keller and James H. Kocsis
866 Increased Rate of Non-Right-Handedness in Patients With Bipolar Disorder.
Cecylia Nowakowska, Gary S. Sachs, Carlos A. Zarate, Jr., Lauren B. Marangell,
Joseph R. Calabrese, Joseph F. Goldberg, and Terence A. Ketter
Book Reviews 868 [PDF]
Electronic CME Activities
Available through www.psychiatrist.com/toc
e13 Diagnostic Dilemmas and Clinical Correlates of Mixed States in Bipolar
Disorder. Mark A. Frye
[Abstract]
e14 Treating Movement Disorders and Akathisia as Side Effects of Antipsychotic
Pharmacotherapy. Peter F. Buckley
[Abstract]
e15 The Role of Psychosocial Interventions in Bipolar II Disorder: What Do We
Know? Holly A. Swartz
[Abstract]